Guardant Health
GH
#1704
Rank
$12.58 B
Marketcap
$94.92
Share price
-3.79%
Change (1 day)
134.60%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

P/S ratio for Guardant Health (GH)

P/S ratio as of May 2026 (TTM): 11.5

According to Guardant Health 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is -125. At the end of 2026 the company had a P/S ratio of 10.3.

P/S ratio history for Guardant Health from 2018 to 2026

PS ratio at the end of each year

Year P/S ratio Change
202610.3-23.64%
202513.5164.39%
20245.09-12.59%
20235.82-6.07%
20226.20-77.22%
202127.2-39.44%
202044.931.28%
201934.2-3.75%
201835.6

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
Neogen
NEOG
2.07-82.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
10.8-6.50%๐Ÿ‡บ๐Ÿ‡ธ USA